Stock Price
47.92
Daily Change
1.14 2.44%
Monthly
1.18%
Yearly
-18.92%
Q1 Forecast
44.95

Recordati reported EUR466.68M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Almirall EUR 517.43M 43.18M Jun/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Orion EUR 302.2M 9.7M Sep/2025
Sanofi EUR 10.51B 1.21B Dec/2025